TREATING HCV INFECTION IN CHRONIC KIDNEY DISEASE IN DEVELOPING COUNTRY: OUR EXPERIENCE WITH LIMITED RESOURCES

摘要

Introduction: HCV infection remains important health problem, which is associated with deleterious consequences in chronic kidney disease patients. Treatment of HCV infection is costly and in developing countries like India, it is often carried on by patients without treat- ment. This study was performed to study efficacy and tolerability of low dose Sofosbuvir and full dose Velpatasvir in HCV positive chronic kidney disease patients.